Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial

OBJECTIVE: To evaluate the efficacy and safety of adjunctive eslicarbazepine acetate (ESL) in patients with refractory partial-onset seizures. METHODS: This randomized, placebo-controlled, double-blind, parallel-group, phase III study was conducted at 173 centers in 19 countries, including the Unite...

Descripción completa

Detalles Bibliográficos
Autores principales: Sperling, Michael R, Abou-Khalil, Bassel, Harvey, Jay, Rogin, Joanne B, Biraben, Arnaud, Galimberti, Carlo A, Kowacs, Pedro A, Hong, Seung Bong, Cheng, Hailong, Blum, David, Nunes, Teresa, Soares-da-Silva, Patrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Full-Length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354260/
https://www.ncbi.nlm.nih.gov/pubmed/25528898
http://dx.doi.org/10.1111/epi.12894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354260/
https://www.ncbi.nlm.nih.gov/pubmed/25528898
http://dx.doi.org/10.1111/epi.12894

Ejemplares similares